Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;14(10):965-967.
doi: 10.1080/17476348.2020.1787836. Epub 2020 Jun 30.

Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

Alireza Tahamtan  1   2 , Masoumeh Tavakoli-Yaraki  3 , Vahid Salimi  4
Affiliations
Editorial

Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

Alireza Tahamtan et al. Expert Rev Respir Med. 2020 Oct.
No abstract available

Keywords: COVID-19; Cannabinoids; RSV; immunomodulators; opioids.

PubMed Disclaimer

References

    1. Stein C. Opioid receptors. Annu Rev Med. 2016;67(1):433–451. - PubMed
    1. Lu H-C MK. An introduction to the endogenous cannabinoid system. Biol Psychiatry. 2016;79(7):516–525. - PMC - PubMed

    2. •• This review is an introduction to the endocannabinoid system (ECS) with an emphasis on its role in synaptic plasticity

    1. McCarthy L, Wetzel M, Sliker JK, et al. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 2001;62(2):111–123. - PubMed

    2. • This is a good review article describing mu-, kappa-, and delta-opioid compounds are able to alter resistance to a variety of infectious agents.

    1. Tanasescu R, Constantinescu CS. Cannabinoids and the immune system: an overview. Immunobiology. 2010;215(8):588–597. - PubMed
    1. Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol. 2013;8(3):608–620. - PMC - PubMed

Publication types

LinkOut - more resources